Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Current Taxes (2009 - 2025)

Grifols' (GIFLF) quarterly Current Taxes came in at $29.1 million in Q4 2025, down 55.36% on a YoY basis from $65.2 million in Q4 2024, and down 55.36% quarter-over-quarter from $65.2 million in Q4 2024.

Analysis

Grifols (GIFLF) Current Taxes (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Current Taxes for 17 consecutive years, with $29.1 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Current Taxes fell 55.36% year-over-year to $29.1 million; the trailing twelve-month figure through Dec 2025 stood at $29.1 million (down 55.36% YoY), and the FY2025 full-year result was $28.2 million, down 39.59% from the prior year.
  • Current Taxes retreated to $29.1 million in Q4 2025 per GIFLF's latest filing, from $65.2 million in the prior quarter.
  • Across five years, Current Taxes topped out at $65.2 million in Q4 2024 and bottomed at $5.2 million in Q4 2021.
  • Historically, Current Taxes has averaged $26.2 million across 5 years, with a median of $16.0 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Current Taxes jumped 317.16% in 2024, then sank 55.36% in 2025.
  • Over 5 years, Current Taxes stood at $5.2 million in 2021, then jumped by 209.8% to $16.0 million in 2022, then dropped by 2.37% to $15.6 million in 2023, then surged by 317.16% to $65.2 million in 2024, then tumbled by 55.36% to $29.1 million in 2025.
  • According to Business Quant data, Current Taxes over the past three periods registered $29.1 million, $65.2 million, and $15.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn 49.00 Mn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 86.90 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 74.18 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn 29.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 29.10 Mn
Dec 31, 2024 65.18 Mn
Dec 31, 2023 15.63 Mn
Dec 31, 2022 16.00 Mn
Dec 31, 2021 5.17 Mn
Dec 31, 2020 4.15 Mn
Dec 31, 2019 6.60 Mn
Dec 31, 2018 2.19 Mn
Jun 30, 2018 24.20 Mn
Dec 31, 2017 7.90 Mn
Jun 30, 2017 23.02 Mn
Dec 31, 2016 8.59 Mn
Sep 30, 2016 24.51 Mn
Jun 30, 2016 36.95 Mn
Dec 31, 2015 17.75 Mn
Sep 30, 2015 43.88 Mn
Jun 30, 2015 107,468.36
Mar 31, 2015 113.58 Mn
Dec 31, 2014 109.31 Mn
Sep 30, 2014 78.87 Mn